NEWS
AmCham News tags
- Accounting / Financial
- AmCham Norway
- Company Profiles
- Education / Research
- Entertainment
- Food & Beverage
- Government
- Healthcare
- Hotel/ Restaurants/ Conferences
- Insurance
- International Leadership Interview Series
- Membership Guide
- Publications
- Rising Leaders
- Technology
- Trade
- Travel
Business News tags
- Accounting / Financial
- Airline / Travel
- Automobile / Transport
- Chemicals / Metals
- Communications/PR/Media
- Culture / Lifestyle
- Defense / Security
- Education / Research
- Energy
- Entertainment & Lifestyle
- Financial / Investment
- Food & Beverage
- Government
- Health
- Human Resources
- Insurance
- IP & Innovation
- Legal
- Management Consulting
- Manufacturing
- Pharmaceutical
- Politics
- Property / Real Estate
- Seafood
- Shipping & Offshore
- Statistics
- Tax
- Technology
- Trade
Interview: Giovanni Caforio, PhRMA Chairman and CEO of Bristol Myers Squibb
Category: Business News
This year our industry has worked tirelessly to combat the COVID-19 virus, including developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections. At the same time, the nation’s political environment remained turbulent, and systemic societal issues were brought to the forefront, all while we continued to socially distance and readjust our work and personal lives around the pandemic.
Source: PhRMA
Published: April 19, 2024
More
Interview: Airthings CEO Øyvind Birkenes
Category: Business News
Airthings was established in 2008 by three CERN scientists with the goal being to educate on the prevalence of radon and offer accurate, user-friendly radon detectors to the masses, making them as common as smoke detectors.
Source: Letting Agent Today
Published: April 19, 2024
More
WSJ: Finland and Norway Avoid Covid-19 Lockdowns but Keep the Virus At Bay
Category: Business News
Tight controls on travel and borders—and political consensus—helped the Nordic nations fight the pandemic.
Source: The Wall Street Journal
Published: April 19, 2024
More
E24: Kreftselskapet Vaccibody får milliardavtale før neste ukes børsnotering
Category: Business News
Det norske kreftvaksineselskapet Vaccibody inngår avtale verdt opptil 6,7 milliarder med internasjonal legemiddelkjempe. Det er den største noensinne i Norge. Vaccibody, som satser på kreftbehandling med immunterapi, har fått en global lisens- og samarbeidsavtale med Genentech, som inngår i legemiddelgiganten Roche Group, ifølge en melding fra selskapet. Les hele saken her
Source: E24
Published: October 1, 2020
More
Dagens Medisin: Allmennlegen «Mo» blir toppsjef i MSD Norge
Category: Business News
Britiske Mohammed «Mo» Ali er legen som ble byråkrat og deretter pharmadirektør. Og som peker på egne pasienter som årsaken til de mange karrierevendingene. – Pasientene mine har vært mine beste karriererådgivere, innleder Mohammed «Mo» Ali, som 1. september begynner i jobben som direktør for MSD Norge. Sammen med kona, som er lege i likhet med […]
Source: Dagens Medisin
Published: August 2, 2020
More